https://arolstar52-zhtest.hf.space/index.php?action=history&feed=atom&title=JWH-015
JWH-015 - 版本历史
2026-07-18T15:30:55Z
本wiki上该页面的版本历史
MediaWiki 1.43.9
https://arolstar52-zhtest.hf.space/index.php?title=JWH-015&diff=4296581&oldid=prev
imported>InternetArchiveBot：Add 1 book for verifiability (20251017sim)) #IABot (v2.0.9.5) (GreenC bot
2025-10-18T00:50:59Z
<p>Add 1 book for verifiability (20251017sim)) #IABot (v2.0.9.5) (<a href="/index.php?title=User:GreenC_bot&action=edit&redlink=1" class="new" title="User:GreenC bot（页面不存在）">GreenC bot</a></p>
<p><b>新页面</b></p><div>{{Expand English|date=2024-01-22}}<br />
{{Drugbox<br />
| Verifiedfields = changed<br />
| Watchedfields = changed<br />
| verifiedrevid = 444488130<br />
| IUPAC_name = (2-Methyl-1-propyl-1''H''-indol-3-yl)-1-naphthalenylmethanone<br />
| image = JWH-015.svg<br />
<br />
<!--Clinical data--><br />
| tradename = <br />
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X --><br />
| pregnancy_US = <!-- A / B / C / D / X --><br />
| pregnancy_category = <br />
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 --><br />
| legal_CA = Schedule II<br />
| legal_UK = Class B<br />
| legal_US = Schedule I<br />
| legal_DE = Anlage II<br />
| routes_of_administration =<br />
<br />
<!--Pharmacokinetic data--><br />
| bioavailability = <br />
| protein_bound = <br />
| metabolism = <br />
| elimination_half-life = <br />
| excretion =<br />
<br />
<!--Identifiers--><br />
| IUPHAR_ligand = 5558<br />
| CAS_number_Ref = {{cascite|correct|??}}<br />
| CAS_number = 155471-08-2<br />
| UNII_Ref = {{fdacite|correct|FDA}}<br />
| UNII = W4FL204T10<br />
| ATC_prefix = <br />
| ATC_suffix = <br />
| PubChem = 4273754<br />
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}<br />
| DrugBank = <br />
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}<br />
| ChemSpiderID = 3480676<br />
<br />
<!--Chemical data--><br />
| C=23 | H=21 | N=1 | O=1 <br />
| smiles = CCCN1C(=C(C2=CC=CC=C21)C(=O)C3=CC=CC4=CC=CC=C43)C<br />
| StdInChI_Ref = {{stdinchicite|changed|chemspider}}<br />
| StdInChI = 1S/C23H21NO/c1-3-15-24-16(2)22(20-12-6-7-14-21(20)24)23(25)19-13-8-10-17-9-4-5-11-18(17)19/h4-14H,3,15H2,1-2H3<br />
| StdInChIKey_Ref = {{stdinchicite|changed|chemspider}}<br />
| StdInChIKey = LJSBBBWQTLXQEN-UHFFFAOYSA-N<br />
}}<br />
'''{{PAGENAMEBASE}}'''，化学名'''2-甲基-1-丙基-3-(1-萘甲酰基)吲哚'''，分子式[[C23H21NO|C<sub>23</sub>H<sub>21</sub>NO]]，属于[[萘甲酰基吲哚]]类[[JWH大麻素列表|JWH系列大麻素]]，由[[约翰·威廉·霍夫曼]]小组合成<ref name="pmid10940540">{{cite journal |vauthors=Aung MM, Griffin G, Huffman JW, Wu M, Keel C, Yang B, Showalter VM, Abood ME, Martin BR | title = Influence of the N-1 alkyl chain length of cannabimimetic indoles upon CB<sub>1</sub> and CB<sub>2</sub>)receptor binding |url=https://archive.org/details/sim_drug-and-alcohol-dependence_2000-08-01_60_2/page/132 | journal = Drug Alcohol Depend | volume = 60 | issue = 2 | pages = 133–40 |date=August 2000 | pmid = 10940540 | doi =10.1016/S0376-8716(99)00152-0 }}</ref>。<br />
<br />
==参考文献==<br />
{{reflist}}<br />
<br />
==外部链接==<br />
<br />
[[Category:策划药]]<br />
[[Category:JWH大麻素]]<br />
[[Category:CB1受体激动剂]]<br />
[[Category:正丙基化合物]]<br />
[[Category:萘甲酰基吲哚]]</div>
imported>InternetArchiveBot